ASX 200 News Weekly Wrap — Magnis, Creso, Cettire, Crown and Commonwealth Bank
We review this week’s ASX news, from MNS and CPH getting caught up in ASIC probes to CBA shares tanking on their latest quarterly.
ASX:CPH
Why is the Creso Share Price Falling? (ASX:CPH)
The Creso Pharma [ASX:CPH] share price is falling as ASIC probes EverBlu Capital, whose executive chairman also serves as CPH’s non-executive chair and co-founder.
Creso Pharma Shares Jumps 12% after Securing New Purchase Orders (ASX:CPH)
The Creso Pharma [ASX:CPH] shares soared in early morning trade after the company announced its wholly-owned Canadian subsidiary, Mernova, secured over $800,000 in new purchase orders.
Creso Pharma Secures New Win in Canada — Shares Up 8% (ASX:CPH)
Aussie pot stock Creso Pharma [ASX:CPH] share price is on the up today. The share price is currently trading 8% higher at time of writing.
Creso Share Price Surges 9% on June Quarter Results (ASX:CPH)
The Creso Pharma Ltd [ASX:CPH] share price is up 9% after the release of its June quarter results. The CPH share price were trading for 12 cents at time of writing...
Creso Share Price Up as Its Subsidiary Announces New MOU (ASX:CPH)
Pot stock Creso Pharma [ASX:CPH] is on the up today. Shares are trading 1.54% higher as the company announced some new developments from its Canadian subsidiary: Halucenex...
CPH Share Price Up on Completed Halucenex Acquisition (ASX:CPH)
The Creso Pharma [ASX:CPH] share price jumped 8% after completing the acquisition of Canadian psychedelics company Halucenex Life Sciences.
Creso Share Price Soars on US Dual Listing (ASX:CPH)
The Creso Pharma Ltd [ASX:CPH] share price jumped 12% after the pot stock completed its US OTC dual listing. CPH shares were up as much as 15% in early trade...
Creso Share Price Up on Expanded Clinical Trial Plans (ASX:CPH)
The Creso Pharma [ASX:CPH] share price rose today after acquisition target Halucenex expands clinical trial recruitment.
Creso Pharma Share Price Dips on Halucenex Update (ASX:CPH)
The CPH share price is down 2.6%. Creso Pharma Ltd [ASX:CPH] came out of a trading halt to announce its acquisition target Halucenex has upped its psilocybin inventory...